Assure (NASDAQ:IONM) Price Target Lowered to $6.00 at Benchmark

Assure (NASDAQ:IONMGet Rating) had its target price dropped by stock analysts at Benchmark from $9.00 to $6.00 in a note issued to investors on Wednesday, The Fly reports. Benchmark’s price target would suggest a potential upside of 128.14% from the company’s current price.

Separately, Zacks Investment Research upgraded shares of Assure from a “sell” rating to a “hold” rating in a report on Thursday, January 20th.

Assure stock traded up $0.13 during trading on Wednesday, hitting $2.63. The stock had a trading volume of 156 shares, compared to its average volume of 7,931. Assure has a 1 year low of $2.25 and a 1 year high of $11.35. The company has a quick ratio of 10.22, a current ratio of 10.22 and a debt-to-equity ratio of 0.47. The stock’s 50 day moving average is $4.99 and its two-hundred day moving average is $5.22. The stock has a market cap of $33.98 million, a price-to-earnings ratio of -8.48 and a beta of 1.44.

Assure (NASDAQ:IONMGet Rating) last released its quarterly earnings results on Monday, May 16th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.13). Assure had a negative return on equity of 11.57% and a negative net margin of 9.44%. During the same quarter in the prior year, the firm posted ($0.10) earnings per share. As a group, equities research analysts anticipate that Assure will post -0.06 EPS for the current fiscal year.

A hedge fund recently bought a new stake in Assure stock. Manatuck Hill Partners LLC bought a new stake in shares of Assure Holdings Corp. (NASDAQ:IONMGet Rating) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 62,500 shares of the company’s stock, valued at approximately $377,000. Manatuck Hill Partners LLC owned approximately 0.53% of Assure as of its most recent filing with the Securities and Exchange Commission. 1.26% of the stock is owned by institutional investors.

Assure Company Profile (Get Rating)

Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services primarily associated with spine and head surgeries. It delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures.

Further Reading

The Fly logo

Receive News & Ratings for Assure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assure and related companies with MarketBeat.com's FREE daily email newsletter.